Avian Influenza Vaccines Market Size, Demand | Forecast 2024-2032

Comments · 66 Views

The global avian influenza vaccines market was valued at US$ 144.6 Million in 2023 and is expected to register a CAGR of 6.3% over the forecast period and reach US$ 250.6 Million in 2032.

The Reports and Insights, a leading market research company, has recently releases report titled “Avian Influenza Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Avian Influenza Vaccines Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Avian Influenza Vaccines?

The global avian influenza vaccines market was valued at US$ 144.6 Million in 2023 and is expected to register a CAGR of 6.3% over the forecast period and reach US$ 250.6 Million in 2032.

What are Avian Influenza Vaccines Market?

Avian influenza vaccines are specifically developed to protect birds, especially poultry, from avian influenza, or bird flu. These vaccines are designed to trigger an immune response in birds, making them resistant to infection. They are critical in preventing the spread of this highly contagious disease among birds, which can lead to significant economic losses in the poultry industry. Vaccination programs are often implemented in regions where the virus is common or where there's a high risk of transmission from wild birds. Additionally, these vaccines help reduce the risk of transmission of avian influenza viruses from birds to humans, though their effectiveness can vary depending on the virus strain.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2338

What are the growth prospects and trends in the Avian Influenza Vaccines Market industry?

The avia influenza vaccines market growth is driven by various factors and trends. The global market for avian influenza vaccines is being primarily driven by the increasing frequency of avian influenza outbreaks, especially within poultry populations. This rise is spurred by the growing demand for poultry products and the necessity to safeguard these populations against highly pathogenic avian influenza (HPAI) strains. Government-led initiatives that advocate for the implementation of vaccination programs in poultry farms to contain the spread of the disease have also played a role in expanding the market. Furthermore, advancements in vaccine technologies, such as the development of recombinant vaccines, have enhanced vaccine effectiveness and safety, thereby propelling market growth. Hence, all these factors contribute to avian influenza vaccines market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Vaccine Type

  • Inactivated Vaccines
  • Live Recombinant Vaccines
  • Combination Vaccines

By Strain Type

  • Low Pathogenicity Avian Influenza
  • High Pathogenicity Avian Influenza

By Application

  • Chicken
  • Duck and Goose
  • Others

By Distribution Channel

  • Veterinary Clinics and Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

North America

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Benelux
  • Nordic
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • ASEAN
  • Australia New Zealand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East Africa

  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Israel
  • Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Hipra
  • IDT Biologika
  • Phibro Animal Health Corporation
  • Vaxxinova
  • Bioveta
  • Vecol
  • Heska Corporation
  • Ringpu (Tianjin) Bio-Pharmacy
  • BioChek

Discover more: https://www.reportsandinsights.com/report/avian-influenza-vaccines-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd.
1820 Avenue M, Brooklyn, NY, 11230, United States
Contact No: +1-(347)-748-1518
Email: [email protected]
Website: https://www.reportsandinsights.com/
Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/
Follow us on twitter: https://twitter.com/ReportsandInsi1

Comments